CDH5 and hyperandrogenism: Although no prior research has explored the connection between hyperandrogenism and CDH5 expression, patients with hyperandrogenic PCOS face a notably elevated risk of ovarian hyperstimulation syndrome (OHSS) and exhibit significantly heightened vascular endothelial cell permeability during hyperovulation.